Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|10|12|1077-1084
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.10, Iss.12, 2003-06, pp. : 1077-1084
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The interest in synthetic siderophore mimics includes therapeutic applications (iron chelation therapy), the design of more effective agents to deliver Fe to plants and the development of new chemical tools for studies of iron metabolism and for a better understanding of iron assimilation processes in living systems. The 8-hydroxyquinoline bidentate chelate moiety offers an alternative to the usual hydroxamic acid, catechol and / or -hydroxycarboxylic acid metal-binding groups encountered in natural siderophores. The promising results obtained by the tris hydroxyquinoline-based ligand O-TRENSOX are summarized. O-TRENSOX exhibits a high and selective affinity for Fe(III) complexation. Its efficiency in delivering Fe to plants as well as its efficiency for iron mobilization, cellular protection and antiproliferative effects have been evidenced. Other chelators of the O-TRENSOX family (mixed catechol / 8-hydroxyquinoline ligands, lipophilic ligands) are also described. Some results question whether the use of partition coefficients is pertinent to foresee the activity of iron chelators. The development of probes (fluorescent, radioactive, spin labelled) based on the OTRENSOX backbone is in progress. 8-hydroxyquinoline iron chelators seem to have a promising future.
Related content
Iron Chelators for the Treatment of Cancer
Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. :
The therapeutic potential of iron chelators
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. :
Iron Chelators in Cancer Chemotherapy
Current Topics in Medicinal Chemistry, Vol. 4, Iss. 15, 2004-11 ,pp. :
Synthetic and Natural Products as Iron Chelators
Current Topics in Medicinal Chemistry, Vol. 11, Iss. 5, 2011-03 ,pp. :
Iron chelators as therapeutic iron depletion agents
By Birch Noah Wang Xiang Chong Hyun-Soon
Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. :